Search results :

Dihydroergotamine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N02CA01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4
Rhinitis 26% 7% x
Nausea 10% 4% x
Application site reaction 6% 2% x
Vomiting 4% 1% x
Pharyngitis 3% 1% x
Somnolence 3% 2% x
Asthenia 1% 0% x x
Fatigue 1% 1% x
Sinusitis 1% 1% x
Dry mouth 1% 1% x
Stiffness 1% 1% x
Hot flush 1% 1% x
Abdominal pain infrequent x
Confusional state infrequent x
Conjunctivitis infrequent x
Cystitis infrequent x
Dysphagia infrequent x
Dyspepsia infrequent x
Ear pain infrequent x
Oedema infrequent x
Body temperature increased infrequent x
Hiccups infrequent x
Hypoaesthesia infrequent x
Cramp muscle infrequent x x
Nervousness infrequent x
Palpitations infrequent x
Petechiae infrequent x
Pruritus infrequent x x
Tachycardia infrequent x
Tinnitus infrequent x
Tremor infrequent x
Upper respiratory tract infection infrequent x
Pollakiuria infrequent x
Vertigo infrequent x
Photophobia infrequent x
Periorbital oedema infrequent x
Muscular weakness infrequent x
Malaise infrequent x
Myalgia infrequent x
Euphoric mood infrequent x
Cerebration impaired infrequent x
Skin cold clammy infrequent x
Lacrimation abnormal NOS infrequent x
Rigors infrequent x
Insomnia infrequent x
Parosmia infrequent x
Abnormal vision infrequent x
Angina pectoris rare x
Anorexia rare x
Anxiety postmarketing, rare x x x x
Aphonia rare x
Arthralgia rare x
Bronchospasm rare x
Bronchitis rare x
Pleuritic pain rare x
Diarrhoea postmarketing, 2% 1% x x x x
Dizziness postmarketing, 4% 2% x x x x
Dyspnoea postmarketing, infrequent x x x x
Epistaxis rare x
Oesophageal spasm rare x
Rash postmarketing, infrequent x x x x
Flushing postmarketing x x x
Headache postmarketing x x x
Herpes simplex rare x
Hypertension postmarketing x x x
Hypotension rare x
Muscle rigidity rare x
Myocardial infarction postmarketing x x x x
Paraesthesia postmarketing, 2% 2% x x x x
Retroperitoneal fibrosis postmarketing x x x x
Shock rare x
Salivary hypersecretion rare x
Speech disorder rare x
Cerebrovascular accident postmarketing x x x
Urticaria rare x
Vaginal inflammation rare x
Yawning rare x
Vasospasm postmarketing x x x
Stupor rare x
Migraine postmarketing x
Eye pain rare x
Muscle contractions involuntary rare x
Peripheral ischaemia rare x
Migraine aggravated rare x
Pelvic inflammatory disease rare x
Influenza-like symptoms rare x
Hyperkinesia rare x
Gait disturbance rare x
Sweating increased postmarketing, infrequent x x x x
Rash papular rare x
Arteriospasm coronary x x x
Hypersensitivity x
Pain x
Swelling x
Ventricular fibrillation x x x x
Ventricular tachycardia x x x x
Trauma x
Myocardial ischaemia x x x
Cold sweat x
Discomfort x
Face oedema x
Tingling sensation x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

DIHYDROERGOTAMINE

Side effects:18
Source:FDA Structured Product Label

dihydroergotamine

Side effects:18
Source:FDA Structured Product Label

dihydroergotamine / DHE 45

Side effects:23
Source:FDA

dihydroergotamine

Side effects:93
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label